ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41.
Liang R, Dou D, Wang C, Huo S, Wu Y, Wang J, Yu Z, Zhang S, Xu J, Liu Y, Liu P, Jiang S, Yu F.
Liang R, et al. Among authors: huo s.
Curr Res Microb Sci. 2024 Jul 9;7:100260. doi: 10.1016/j.crmicr.2024.100260. eCollection 2024.
Curr Res Microb Sci. 2024.
PMID: 39129758
Free PMC article.